Global Seasonal Influenza Vaccines Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Seasonal Influenza Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Seasonal Influenza Vaccines market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Seasonal Influenza Vaccines market include Changsheng Bio-Technology, Sanofi, Novartis International AG, Merck & Co., Inc., Pfizer Inc, GlaxoSmithKline plc, AstraZeneca, Viatris Inc. and Vaxess Technologies Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Seasonal Influenza Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Seasonal Influenza Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Seasonal Influenza Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Seasonal Influenza Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Seasonal Influenza Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Seasonal Influenza Vaccines sales, projected growth trends, production technology, application and end-user industry.
Seasonal Influenza Vaccines Segment by Company
Changsheng Bio-Technology
Sanofi
Novartis International AG
Merck & Co., Inc.
Pfizer Inc
GlaxoSmithKline plc
AstraZeneca
Viatris Inc.
Vaxess Technologies Inc
Sinovac Biotech Ltd
SINOVAC
OSIVAX
Jiangsu Simcere Vaxtec Bio-pharmaceutical
EMERGEX VACCINES
EMERGENT
Dalian Hissen Bio-pharm
CSL Limited
Ccbio SA
Aleph Biomedical
Abbott Laboratories
Seasonal Influenza Vaccines Segment by Type
Type B
Type A (H3N2)
Type A (H1N1)
Seasonal Influenza Vaccines Segment by Application
Adults
Pediatrics
Elderly
Adolescence
Seasonal Influenza Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Seasonal Influenza Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Seasonal Influenza Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Seasonal Influenza Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Seasonal Influenza Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Seasonal Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Influenza Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Seasonal Influenza Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Seasonal Influenza Vaccines industry.
Chapter 3: Detailed analysis of Seasonal Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Seasonal Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Seasonal Influenza Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Seasonal Influenza Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Seasonal Influenza Vaccines market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Seasonal Influenza Vaccines market include Changsheng Bio-Technology, Sanofi, Novartis International AG, Merck & Co., Inc., Pfizer Inc, GlaxoSmithKline plc, AstraZeneca, Viatris Inc. and Vaxess Technologies Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Seasonal Influenza Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Seasonal Influenza Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Seasonal Influenza Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Seasonal Influenza Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Seasonal Influenza Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Seasonal Influenza Vaccines sales, projected growth trends, production technology, application and end-user industry.
Seasonal Influenza Vaccines Segment by Company
Changsheng Bio-Technology
Sanofi
Novartis International AG
Merck & Co., Inc.
Pfizer Inc
GlaxoSmithKline plc
AstraZeneca
Viatris Inc.
Vaxess Technologies Inc
Sinovac Biotech Ltd
SINOVAC
OSIVAX
Jiangsu Simcere Vaxtec Bio-pharmaceutical
EMERGEX VACCINES
EMERGENT
Dalian Hissen Bio-pharm
CSL Limited
Ccbio SA
Aleph Biomedical
Abbott Laboratories
Seasonal Influenza Vaccines Segment by Type
Type B
Type A (H3N2)
Type A (H1N1)
Seasonal Influenza Vaccines Segment by Application
Adults
Pediatrics
Elderly
Adolescence
Seasonal Influenza Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Seasonal Influenza Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Seasonal Influenza Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Seasonal Influenza Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Seasonal Influenza Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Seasonal Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Influenza Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Seasonal Influenza Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Seasonal Influenza Vaccines industry.
Chapter 3: Detailed analysis of Seasonal Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Seasonal Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Seasonal Influenza Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
201 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Seasonal Influenza Vaccines Sales Value (2020-2031)
- 1.2.2 Global Seasonal Influenza Vaccines Sales Volume (2020-2031)
- 1.2.3 Global Seasonal Influenza Vaccines Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Seasonal Influenza Vaccines Market Dynamics
- 2.1 Seasonal Influenza Vaccines Industry Trends
- 2.2 Seasonal Influenza Vaccines Industry Drivers
- 2.3 Seasonal Influenza Vaccines Industry Opportunities and Challenges
- 2.4 Seasonal Influenza Vaccines Industry Restraints
- 3 Seasonal Influenza Vaccines Market by Company
- 3.1 Global Seasonal Influenza Vaccines Company Revenue Ranking in 2024
- 3.2 Global Seasonal Influenza Vaccines Revenue by Company (2020-2025)
- 3.3 Global Seasonal Influenza Vaccines Sales Volume by Company (2020-2025)
- 3.4 Global Seasonal Influenza Vaccines Average Price by Company (2020-2025)
- 3.5 Global Seasonal Influenza Vaccines Company Ranking (2023-2025)
- 3.6 Global Seasonal Influenza Vaccines Company Manufacturing Base and Headquarters
- 3.7 Global Seasonal Influenza Vaccines Company Product Type and Application
- 3.8 Global Seasonal Influenza Vaccines Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Seasonal Influenza Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Seasonal Influenza Vaccines Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Seasonal Influenza Vaccines Market by Type
- 4.1 Seasonal Influenza Vaccines Type Introduction
- 4.1.1 Type B
- 4.1.2 Type A (H3N2)
- 4.1.3 Type A (H1N1)
- 4.2 Global Seasonal Influenza Vaccines Sales Volume by Type
- 4.2.1 Global Seasonal Influenza Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Seasonal Influenza Vaccines Sales Volume by Type (2020-2031)
- 4.2.3 Global Seasonal Influenza Vaccines Sales Volume Share by Type (2020-2031)
- 4.3 Global Seasonal Influenza Vaccines Sales Value by Type
- 4.3.1 Global Seasonal Influenza Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Seasonal Influenza Vaccines Sales Value by Type (2020-2031)
- 4.3.3 Global Seasonal Influenza Vaccines Sales Value Share by Type (2020-2031)
- 5 Seasonal Influenza Vaccines Market by Application
- 5.1 Seasonal Influenza Vaccines Application Introduction
- 5.1.1 Adults
- 5.1.2 Pediatrics
- 5.1.3 Elderly
- 5.1.4 Adolescence
- 5.2 Global Seasonal Influenza Vaccines Sales Volume by Application
- 5.2.1 Global Seasonal Influenza Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Seasonal Influenza Vaccines Sales Volume by Application (2020-2031)
- 5.2.3 Global Seasonal Influenza Vaccines Sales Volume Share by Application (2020-2031)
- 5.3 Global Seasonal Influenza Vaccines Sales Value by Application
- 5.3.1 Global Seasonal Influenza Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Seasonal Influenza Vaccines Sales Value by Application (2020-2031)
- 5.3.3 Global Seasonal Influenza Vaccines Sales Value Share by Application (2020-2031)
- 6 Seasonal Influenza Vaccines Regional Sales and Value Analysis
- 6.1 Global Seasonal Influenza Vaccines Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Seasonal Influenza Vaccines Sales by Region (2020-2031)
- 6.2.1 Global Seasonal Influenza Vaccines Sales by Region: 2020-2025
- 6.2.2 Global Seasonal Influenza Vaccines Sales by Region (2026-2031)
- 6.3 Global Seasonal Influenza Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Seasonal Influenza Vaccines Sales Value by Region (2020-2031)
- 6.4.1 Global Seasonal Influenza Vaccines Sales Value by Region: 2020-2025
- 6.4.2 Global Seasonal Influenza Vaccines Sales Value by Region (2026-2031)
- 6.5 Global Seasonal Influenza Vaccines Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Seasonal Influenza Vaccines Sales Value (2020-2031)
- 6.6.2 North America Seasonal Influenza Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Seasonal Influenza Vaccines Sales Value (2020-2031)
- 6.7.2 Europe Seasonal Influenza Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Seasonal Influenza Vaccines Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Seasonal Influenza Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Seasonal Influenza Vaccines Sales Value (2020-2031)
- 6.9.2 South America Seasonal Influenza Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Seasonal Influenza Vaccines Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Seasonal Influenza Vaccines Sales Value Share by Country, 2024 VS 2031
- 7 Seasonal Influenza Vaccines Country-level Sales and Value Analysis
- 7.1 Global Seasonal Influenza Vaccines Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Seasonal Influenza Vaccines Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Seasonal Influenza Vaccines Sales by Country (2020-2031)
- 7.3.1 Global Seasonal Influenza Vaccines Sales by Country (2020-2025)
- 7.3.2 Global Seasonal Influenza Vaccines Sales by Country (2026-2031)
- 7.4 Global Seasonal Influenza Vaccines Sales Value by Country (2020-2031)
- 7.4.1 Global Seasonal Influenza Vaccines Sales Value by Country (2020-2025)
- 7.4.2 Global Seasonal Influenza Vaccines Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.9.2 France Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.16.2 China Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.19.2 India Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Seasonal Influenza Vaccines Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Seasonal Influenza Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Seasonal Influenza Vaccines Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Changsheng Bio-Technology
- 8.1.1 Changsheng Bio-Technology Comapny Information
- 8.1.2 Changsheng Bio-Technology Business Overview
- 8.1.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
- 8.1.5 Changsheng Bio-Technology Recent Developments
- 8.2 Sanofi
- 8.2.1 Sanofi Comapny Information
- 8.2.2 Sanofi Business Overview
- 8.2.3 Sanofi Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Sanofi Seasonal Influenza Vaccines Product Portfolio
- 8.2.5 Sanofi Recent Developments
- 8.3 Novartis International AG
- 8.3.1 Novartis International AG Comapny Information
- 8.3.2 Novartis International AG Business Overview
- 8.3.3 Novartis International AG Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Novartis International AG Seasonal Influenza Vaccines Product Portfolio
- 8.3.5 Novartis International AG Recent Developments
- 8.4 Merck & Co., Inc.
- 8.4.1 Merck & Co., Inc. Comapny Information
- 8.4.2 Merck & Co., Inc. Business Overview
- 8.4.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.4.4 Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
- 8.4.5 Merck & Co., Inc. Recent Developments
- 8.5 Pfizer Inc
- 8.5.1 Pfizer Inc Comapny Information
- 8.5.2 Pfizer Inc Business Overview
- 8.5.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.5.4 Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
- 8.5.5 Pfizer Inc Recent Developments
- 8.6 GlaxoSmithKline plc
- 8.6.1 GlaxoSmithKline plc Comapny Information
- 8.6.2 GlaxoSmithKline plc Business Overview
- 8.6.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.6.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
- 8.6.5 GlaxoSmithKline plc Recent Developments
- 8.7 AstraZeneca
- 8.7.1 AstraZeneca Comapny Information
- 8.7.2 AstraZeneca Business Overview
- 8.7.3 AstraZeneca Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.7.4 AstraZeneca Seasonal Influenza Vaccines Product Portfolio
- 8.7.5 AstraZeneca Recent Developments
- 8.8 Viatris Inc.
- 8.8.1 Viatris Inc. Comapny Information
- 8.8.2 Viatris Inc. Business Overview
- 8.8.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.8.4 Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
- 8.8.5 Viatris Inc. Recent Developments
- 8.9 Vaxess Technologies Inc
- 8.9.1 Vaxess Technologies Inc Comapny Information
- 8.9.2 Vaxess Technologies Inc Business Overview
- 8.9.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.9.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
- 8.9.5 Vaxess Technologies Inc Recent Developments
- 8.10 Sinovac Biotech Ltd
- 8.10.1 Sinovac Biotech Ltd Comapny Information
- 8.10.2 Sinovac Biotech Ltd Business Overview
- 8.10.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.10.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
- 8.10.5 Sinovac Biotech Ltd Recent Developments
- 8.11 SINOVAC
- 8.11.1 SINOVAC Comapny Information
- 8.11.2 SINOVAC Business Overview
- 8.11.3 SINOVAC Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.11.4 SINOVAC Seasonal Influenza Vaccines Product Portfolio
- 8.11.5 SINOVAC Recent Developments
- 8.12 OSIVAX
- 8.12.1 OSIVAX Comapny Information
- 8.12.2 OSIVAX Business Overview
- 8.12.3 OSIVAX Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.12.4 OSIVAX Seasonal Influenza Vaccines Product Portfolio
- 8.12.5 OSIVAX Recent Developments
- 8.13 Jiangsu Simcere Vaxtec Bio-pharmaceutical
- 8.13.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Comapny Information
- 8.13.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview
- 8.13.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.13.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
- 8.13.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
- 8.14 EMERGEX VACCINES
- 8.14.1 EMERGEX VACCINES Comapny Information
- 8.14.2 EMERGEX VACCINES Business Overview
- 8.14.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.14.4 EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
- 8.14.5 EMERGEX VACCINES Recent Developments
- 8.15 EMERGENT
- 8.15.1 EMERGENT Comapny Information
- 8.15.2 EMERGENT Business Overview
- 8.15.3 EMERGENT Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.15.4 EMERGENT Seasonal Influenza Vaccines Product Portfolio
- 8.15.5 EMERGENT Recent Developments
- 8.16 Dalian Hissen Bio-pharm
- 8.16.1 Dalian Hissen Bio-pharm Comapny Information
- 8.16.2 Dalian Hissen Bio-pharm Business Overview
- 8.16.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.16.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
- 8.16.5 Dalian Hissen Bio-pharm Recent Developments
- 8.17 CSL Limited
- 8.17.1 CSL Limited Comapny Information
- 8.17.2 CSL Limited Business Overview
- 8.17.3 CSL Limited Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.17.4 CSL Limited Seasonal Influenza Vaccines Product Portfolio
- 8.17.5 CSL Limited Recent Developments
- 8.18 Ccbio SA
- 8.18.1 Ccbio SA Comapny Information
- 8.18.2 Ccbio SA Business Overview
- 8.18.3 Ccbio SA Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.18.4 Ccbio SA Seasonal Influenza Vaccines Product Portfolio
- 8.18.5 Ccbio SA Recent Developments
- 8.19 Aleph Biomedical
- 8.19.1 Aleph Biomedical Comapny Information
- 8.19.2 Aleph Biomedical Business Overview
- 8.19.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.19.4 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
- 8.19.5 Aleph Biomedical Recent Developments
- 8.20 Abbott Laboratories
- 8.20.1 Abbott Laboratories Comapny Information
- 8.20.2 Abbott Laboratories Business Overview
- 8.20.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.20.4 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
- 8.20.5 Abbott Laboratories Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Seasonal Influenza Vaccines Value Chain Analysis
- 9.1.1 Seasonal Influenza Vaccines Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Seasonal Influenza Vaccines Sales Mode & Process
- 9.2 Seasonal Influenza Vaccines Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Seasonal Influenza Vaccines Distributors
- 9.2.3 Seasonal Influenza Vaccines Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
